Park Ha Biological Technology Closes $2M Offering, Significantly Diluting Shares
BYAH sits 57% above its 52-week low of $0.93 on elevated volume (4.6× avg).
Summary
Park Ha Biological Technology Co., Ltd. announced the closing of its $2.0 million registered direct offering. This follows the pricing announcement on June 12th and a 424B5 filing earlier today that finalized the offering. The capital raise is highly dilutive, representing over 40% of the company's current market capitalization. This funding provides critical working capital for the micro-cap company, which has reported significant net losses and recently opted to bypass certain Nasdaq corporate governance rules.
At the time of this announcement, BYAH was trading at $1.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $0.93 to $2,074.50. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.